![‘Vaccines have saved more lives than any other medicines’- Robin Shattock](http://www.imperial.ac.uk/ImageCropToolT4/imageTool/uploaded-images/newseventsimage_1605266267155_featurenews2012_x1.jpg)
![shadow](http://www.imperial.ac.uk/assets/news/img/image_shadow_sidebar.png)
Vaccine Confidence
‘Vaccines have saved more lives than any other medicines’- Robin Shattock
A top vaccine expert has tackled public concerns that a rapid rollout of COVID immunisation programme would be unsafe.
‘Vaccines have saved more lives than any other medicines’- Robin Shattock
A top vaccine expert has tackled public concerns that a rapid rollout of COVID immunisation programme would be unsafe.
Robin Shattock says 'we could be living with COVID-19 for years to come'
Imperial’s COVID-19 vaccine lead, Professor Robin Shattock, has told MPs we could be living with the virus for years to come.
UK researchers to explore human challenge studies for COVID-19
Researchers are set to explore a human challenge study with the virus that causes COVID-19, the first such study anywhere in the world.
Imperial agree vaccine research and education collaboration with Indonesia
Imperial has agreed a pioneering research and education collaboration with Indonesia to advance vaccine development and help tackle COVID-19.
Robin Shattock tells MEPs of ‘promising’ vaccine progress
Professor Robin Shattock, the lead for Imperial's COVID-19 vaccine, updated the European Parliament today on the progress of his team's vaccine.
Landmark coronavirus study to trial inhaled Imperial and Oxford vaccines
A small clinical study will explore the effects of delivering the vaccines to the airways.
Largest global vaccine confidence survey reveals hesitancy hotspots
While vaccine confidence remains low in Europe, there are signs that public trust in vaccine safety has been increasing in some EU countries.
Audio
Podcast: COVID-19 vaccine trials latest and privacy in contact tracing
In this edition: Results of the COVID-19 vaccine animal trials and the latest news from the human trials, plus privacy in contact tracing apps.
Best COVID-19 vaccine 'may not be the first'
In a week in which Russia approved its 'Sputnik V' coronavirus vaccine, a leading Imperial expert sounds a note of caution on the need for data.
Audio
Podcast: COVID-19 vaccine trials, neurodiversity in focus, and poet in residence
In this edition: A participant in Imperial’s COVID-19 vaccine trial, a professor who set up a neurodiversity network, and our new poet in residence.